Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy-Reference-Cited by-同舟云学术

Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy

Published:2019-03-12 Issue:11 Volume:139 Page:1461-1462
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Nota Nienke M.¹,Wiepjes Chantal M.¹,de Blok Christel J.M.¹,Gooren Louis J.G.¹,Kreukels Baudewijntje P.C.²,den Heijer Martin¹

Affiliation:

1. Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Department of Internal Medicine, Division of Endocrinology, the Netherlands (N.M.N., C.M.W., C.J.M.d.B., L.J.G.G., M.d.H.).

2. Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Department of Medical Psychology, Amsterdam Public Health, the Netherlands (B.P.C.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy

2. Incidence of first acute myocardial infarction in the Netherlands.;Koek HL;Neth J Med,2007

3. Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism

4. Nationwide incidence of first stroke and TIA in the Netherlands

5. Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transgender patients and gender-affirming hormone therapy through the mid-life;Maturitas;2024-11

2. Gender and contemporary risk of adverse events in atrial fibrillation;European Heart Journal;2024-09-01

3. Evaluating the risk of venous thromboembolism in transfeminine and gender diverse people: A retrospective analysis.;Endocrine Practice;2024-09

4. Testosterone and other treatments for transgender males and non-binary trans masculine individuals;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

5. Metabolic and cardiovascular risks of hormone treatment for transgender individuals;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09